{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:25:38Z","timestamp":1787073938033,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clinthera.2026.06.023","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:18:48Z","timestamp":1785237528000},"page":"887-892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Federal Rescheduling of Medical Cannabis: A Long-Overdue Opportunity to Lead with Science and Patient Care Realities"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-3007","authenticated-orcid":false,"given":"Julie K.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7122-0039","authenticated-orcid":false,"given":"Drudys","family":"Ledbetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steph","family":"Sherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinthera.2026.06.023_bib0001","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinthera.2023.04.011","article-title":"History of cannabis regulation and medicinal therapeutics: It\u2019s complicated","volume":"45","author":"Johnson","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jama.2025.19433","article-title":"Therapeutic use of cannabis and cannabinoids","volume":"335","author":"Hsu","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0003","unstructured":"United Nations Office of Drugs and Crime. World drug report (2025). 2025. Accessed June 1, 2026. https:\/\/www.unodc.org\/documents\/data-and-analysis\/WDR_2025\/WDR25_Special_points_of_interest.pdf"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0004","series-title":"2022-2024 NSDUH: Past Year Marijuana Use or Past Year Opioid Misuse By Population Characteristics","year":"2025"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0005","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/add.70117","article-title":"Understanding medical cannabis use internationally: why definitions and context matter","volume":"120","author":"Graham","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0006","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.yebeh.2016.11.033","article-title":"Historical perspective on the medical use of cannabis for epilepsy: ancient times to the 1980s","volume":"70","author":"Friedman","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0007","unstructured":"Melnik M., Stewart B., Breest K. et al. The research and development ecosystem: engine of the Massachusetts economy. University of Massachusetts Donahue Institute. Hadley, MA. 2026. Accessed June 19, 2026. https:\/\/donahue.umass.edu\/documents\/Federal_Funding_Phase_II_Report_March_2026.pdf."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0008","first-page":"689","article-title":"The colors of cannabis: race and marijuana","volume":"50","author":"Bender","year":"2016","journal-title":"UC Davis L Rev"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0009","series-title":"The Marijuana Conviction: A History of Marijuana Prohibition in the United States","author":"Richard","year":"1999"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0010","unstructured":"United States Drug Enforcement Administration (DEA). Title 21 United States Code (USC) Controlled Substances Act."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0011","unstructured":"Drug Enforcement Administration (DEA). Controlled substance schedules: marijuana. U.S. Department of Justice (DOJ). Accessed June 19, 2026. https:\/\/www.dea.gov\/drug-information\/drug-scheduling."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0012","doi-asserted-by":"crossref","unstructured":"Buxton J. The historical foundations of the narcotic drug control regime. Work Bank Policy Research Working Paper 4553. 2008. Accessed June 19, 2026. https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=1106042","DOI":"10.1596\/1813-9450-4553"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0013","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0955-3959(99)00031-6","article-title":"History of medical marijuana policy in US","volume":"10","author":"Zeese","year":"1999","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0014","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00263206.2011.553890","article-title":"Cannabis prohibition in Egypt, 1880\u20131939: from local ban to league of nations diplomacy","volume":"47","author":"Kozma","year":"2011","journal-title":"Middle East Stud"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1360-0443.2003.00273.x","article-title":"Cannabis condemned: the proscription of Indian hemp","volume":"98","author":"Kendell","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0016","series-title":"Research Handbook on International Drug Policy","article-title":"The evolution of international drug control under the United Nations","author":"S\u00e1nchez Avil\u00e9s","year":"2020"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0017","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugpo.2011.08.003","article-title":"Regime change: re-visiting the 1961 single convention on narcotic drugs","volume":"23","author":"Bewley-Taylor","year":"2012","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0018","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/aju.2020.55","article-title":"A brief history of cannabis and the drug conventions","volume":"114","author":"Collins","year":"2020","journal-title":"AJIL Unbound"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0019","unstructured":"Expert Committee on Drug Dependence (ECDD). Resolution 52\/5\u2014exploration of all aspects related to the use of cannabis seeds for illicit purposes. World Health Organization. Geneva, Switzerland. 2009. Accessed June 19, 2026. https:\/\/cdn.who.int\/media\/docs\/default-source\/controlled-substances\/cnd-res-52-5.pdf?sfvrsn=aaaa3509_2&download=true."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0020","unstructured":"Department of Health Products Policies and Standards. WHO review of cannabis and cannabis-related substances. World Health Organization. Geneva, Switzerland. Accessed June 19, 2026. https:\/\/www.who.int\/teams\/health-product-and-policy-standards\/controlled-substances\/who-review-of-cannabis-and-cannabis-related-substances."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/2168479017694850","article-title":"Overview of FDA\u2019s expanded access program for investigational drugs","volume":"51","author":"Jarow","year":"2017","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0022","unstructured":"National Conferences of State Legislatures. State medical cannabis laws. Denver, CO. Updated June 1, 2026. Accessed June 19, 2026. https:\/\/www.ncsl.org\/health\/state-medical-cannabis-laws."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0023","unstructured":"National Conferences of State Legislatures. Cannabis Review. Denver, CO. Updated June 20, 2024. Accessed June 19, 2026. https:\/\/www.ncsl.org\/civil-and-criminal-justice\/cannabis-overview."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0024","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.clinthera.2023.01.017","article-title":"Medical cannabis program sustainability in the era of recreational cannabis","volume":"45","author":"Colby","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0025","series-title":"Project Destigmatize HealTHCare","article-title":"Operationalizing schedule III: a Massachusetts policy framework for clinical cannabis integration and patient protection","author":"Ledbetter","year":"2026"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0026","unstructured":"Kohli D., Nickerson S. How a \u2018Well-Known Secret\u2019 in Massachusetts Cannabis Testing is Obscuring What\u2019s in Your Weed. Boston Globe. Boston, MA. 2024. Accessed June 19, 2026. https:\/\/www.bostonglobe.com\/2024\/09\/27\/business\/cannabis-lab-shopping-testing-dispensary-weed-moldy\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0027","unstructured":"Cannabis Regulators Association. Overview of DOJ final order on marijuana rescheduling. 2026. Accessed June 19, 2026. https:\/\/static1.squarespace.com\/static\/5f7e577e23ad7c718c269776\/t\/69ef671deb38f3461212a4e9\/1777297181494\/Overview+of+April+23+DOJ+Final+Order+on+Rescheduling_Final.pdf."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0028","unstructured":"Sherer, S. Medical cannabis and cannabinoid act: federal legislation toolkit. Americans for Safe Access (ASA). Washington, DC; 2026. Accessed June 19, 2026. https:\/\/www.safeaccessnow.org\/fedlegkit#gsc.tab=0."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0029","unstructured":"Sherer, S. Federal guidance needed: ag order no. 6754-2026: rationale for immediate action. 2026. Americans for Safe Access (ASA). Washington, DC, 2026. Accessed June 19, 2026. https:\/\/assets.nationbuilder.com\/americansforsafeaccess\/pages\/40785\/attachments\/original\/1779949493\/AG_Order_No._6754-2026_Rationale_for_Immediate_Action.pdf?1779949493."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0030","series-title":"Assistant Secretary for Health. Basis for the recommendation to reschedule marijuana into schedule III of the controlled substances act","year":"2023"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0031","unstructured":"Trump, D. Increasing Medical Marijuana and Cannabidiol Research. Executive Order. The White House. Washington, DC, 2025. Accessed June 19, 2026. https:\/\/www.whitehouse.gov\/presidential-actions\/2025\/12\/increasing-medical-marijuana-and-cannabidiol-research\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0032","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s42238-025-00264-0","article-title":"State funding for cannabis research: an analysis of funding mechanisms and levels","volume":"7","author":"Balla","year":"2025","journal-title":"J Cannabis Res"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0033","unstructured":"Commonwealth of Pennsylvania. Clinical Research (Chapter 20). Harrisburg, PA. Accessed June 19, 2026. https:\/\/www.pa.gov\/agencies\/health\/programs\/medical-marijuana\/clinical-research."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0034","unstructured":"Margaret J. Shannon O\u2019Brien\u2019s Quest to Make Massachusetts a Cannabis Research Hub. MJBizDaily. New York, NY; 2026. Accessed June 19, 2026. https:\/\/mjbizdaily.com\/news\/shannon-obriens-quest-to-make-massachusetts-a-cannabis-research-hub\/614448\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0035","unstructured":"WCBV5. Massachusetts becomes first legal pot state to add AAA\u2019s cannabis curriculum to driver\u2019s ed. ABC. Boston, MA, 2022. Accessed June 19, 2026. https:\/\/www.wcvb.com\/article\/massachusetts-becomes-first-in-nation-to-add-cannabis-curriculum-to-drivers-ed\/42228303."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0036","unstructured":"Cannabis Control Commission Massachusetts. Research. Commonwealth of Massachusetts. Worcester, MA, 2026. Accessed June 19, 2026. https:\/\/masscannabiscontrol.com\/research\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0037","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.clinthera.2023.03.011","article-title":"Let\u2019s match: making cannabis policy guided by research","volume":"45","author":"Donahue","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0038","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinthera.2025.12.005","article-title":"Cannabis research, policy, and therapeutics\u2014an International Quasi-Experiment in Cannabis Policy\u2014Part 1 (2026)","volume":"48","author":"Johnson","year":"2026","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.clinthera.2026.06.023_bib0039","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.clinthera.2023.01.017","article-title":"Medical cannabis program sustainability in the era of recreational cannabis","volume":"45","author":"Colby","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0040","unstructured":"Johnson J.K., O\u2019Brien S. Can Massachusetts Lead the Way in Medical Cannabis Research? A Proposed Center for Cannabis Research and Policy Could Serve as a Statewide Hub Uniting Social Policy Research With Biomedical and Clinical Studies. Boston Globe. Boston, MA. 2026. Accessed June 19, 2026. https:\/\/www.bostonglobe.com\/2026\/01\/12\/opinion\/cannabis-medical-research-massachusetts-center\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0041","unstructured":"Schoenberg S. Could Massachusetts Become a Cannabis Research Hub? Not Without More Federal and State Support, Experts Say. Commonwealth Beacon. Boston, MA. 2022. Accessed June 19, 2026. https:\/\/commonwealthbeacon.org\/marijuana\/could-massachusetts-become-a-cannabis-research-hub\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0042","unstructured":"Editorial Board. Rescheduling Marijuana Opens Opportunity for Research, Tax Fairness. Boston Globe. Boston, MA. 2025. Accessed June 19, 2026. https:\/\/www.bostonglobe.com\/2025\/12\/23\/opinion\/marijuana-rescheduling-cannabis-trump\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0043","unstructured":"Rawson J. An Open Letter to the New CCC Members About Testing and Transparency. Talking Joints Memo. Worcester, MA. 2026. Accessed June 19, 2026. https:\/\/talkingjointsmemo.com\/an-open-letter-to-the-new-ccc-members-about-testing-and-transparency."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0044","unstructured":"Cannabis Control Commission Massachusetts. Massachusetts adult-use cannabis sales generated $1.65 billion. Commonwealth of Massachusetts. Worcester, MA, 2026. Accessed June 19, 2026. https:\/\/masscannabiscontrol.com\/2026\/01\/massachusetts-adult-use-cannabis-sales-generated-1-65-billion-in-2025\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0045","unstructured":"Rawson J. Analysis: what is missing from the new Massachusetts cannabis industry report. Talking Joints Memo. 2025. Accessed June 19, 2026. https:\/\/talkingjointsmemo.com\/analysis-what-is-missing-from-the-new-massachusetts-cannabis-industry-report\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0046","unstructured":"Kohli D. Cannabis Commission Research Chief Takes Medical Leave After Alleging \u2018Inappropriate\u2019 and \u2018Harmful\u2019 Behaviors by Leaders. Boston Globe. Boston, MA. 2024. Accessed June 19, 2026. https:\/\/www.bostonglobe.com\/2024\/09\/18\/business\/julie-k-johnson-cannabis-control-commission-research-chief\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0047","unstructured":"Casey E. Cannabis agency reaches $305K settlement with former communications chief, as total spent on employee disputes reaches $1.5M. WBJ. 2025. Accessed June 19, 2026. https:\/\/wbjournal.com\/article\/cannabis-agency-reaches-305k-settlement-with-former-communications-chief-as-total-spent-on\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2025.12.011","article-title":"Safeguarding cannabis for medical use: clinical risks, regulatory gaps, and the path toward equitable standards","author":"Collins","year":"2026","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0049","unstructured":"Sherer S. Press advisory: medical cannabis stakeholders call on states for a compassionate response to hemp laws. Washington, DC, 2026. Accessed June 20, 2026. https:\/\/www.safeaccessnow.org\/press_advisory_patient_advocates_provide_states_with_response_to_hemp_laws#gsc.tab=0."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0050","unstructured":"Schienberg S. Massachusetts marijuana research czar envisions open database, annual conference. Masslive. Boston, MA. 2026. Accessed June 19, 2026. https:\/\/www.masslive.com\/politics\/2018\/06\/massachusetts_marijuana_resear.html."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0051","unstructured":"Boston 7 News. Researchers: Evidence Insufficient to Back THC Concentration Cap. WHDH TV 7 NEWS WLVITV CW56. Boston, MA. 2021. Accessed June 19, 2026. https:\/\/whdh.com\/news\/researchers-evidence-insufficient-to-back-thc-concentration-cap\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0052","unstructured":"Borkhetaria B. Massachusetts Cannabis Industry Struggles With Diversity in Senior Leadership Despite Equity Mandates. Commonwealth Beacon. 2025. Accessed June 19, 2026. https:\/\/commonwealthbeacon.org\/marijuana\/massachusetts-cannabis-industry-struggles-with-diversity-in-senior-leadership-despite-equity-mandates\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0053","unstructured":"Casey E., Adams D. Failed oversight: beset by infighting, a toxic culture, and an investigation into its leadership, the Cannabis Control Commission isn\u2019t effectively performing its. WBJ. 2024. Accessed June 19, 2026. https:\/\/wbjournal.com\/article\/failed-oversight-beset-by-infighting-a-toxic-culture-and-an-investigation-into-its\/."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0054","unstructured":"Garisto D. Trump order gives political appointees vast powers over research grants. Nature. 2025. Accessed June 19, 2026. https:\/\/www.nature.com\/articles\/d41586-025-02557-z."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0055","unstructured":"Warren B., Wernau J. Legal marijuana contains dangerous mold. States approve it anyway. Wall Street J. 2024. Accessed June 19, 2026. https:\/\/www.wsj.com\/health\/healthcare\/marijuana-mold-contaminants-safety-a172c230."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0056","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12954-024-00929-8","article-title":"The role of stigma in cannabis use disclosure: an exploratory study","volume":"21","author":"King","year":"2024","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0057","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11677","article-title":"Comparison of medical cannabis use reported on a confidential survey vs documented in the electronic health record among primary care patients","volume":"5","author":"Lapham","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0058","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.35049","article-title":"Developing medical cannabis competencies","volume":"8","author":"Zolotov","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clinthera.2026.06.023_bib0059","unstructured":"Centers for Medicare and Medicaid Services (CMS). CMS Marks Milestone in Expanding Patient-Centered Innovation with Substance Access Beneficiary Engagement Incentive. Centers for Medicare and Medicaid Services (CMS). Baltimore, MD. 2026. Accessed June 19, 2026. https:\/\/www.cms.gov\/newsroom\/press-releases\/cms-marks-milestone-expanding-patient-centered-innovation-substance-access-beneficiary-engagement."},{"key":"10.1016\/j.clinthera.2026.06.023_bib0060","unstructured":"Massachusetts Chapter 94G Section 17: Research agenda; social and economic trends and public health impacts of marijuana. Massachusetts Legislature. Boston, MA. 2017. Accessed June 19, 2026. https:\/\/malegislature.gov\/Laws\/GeneralLaws\/PartI\/TitleXV\/Chapter94G\/Section17."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:33:12Z","timestamp":1787070792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826002389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0149291826002389"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.06.023","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Federal Rescheduling of Medical Cannabis: A Long-Overdue Opportunity to Lead with Science and Patient Care Realities","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}